396 related articles for article (PubMed ID: 9404448)
1. Two years of replacement therapy in adults with growth hormone deficiency.
Verhelst J; Abs R; Vandeweghe M; Mockel J; Legros JJ; Copinschi G; Mahler C; Velkeniers B; Vanhaelst L; Van Aelst A; De Rijdt D; Stevenaert A; Beckers A
Clin Endocrinol (Oxf); 1997 Oct; 47(4):485-94. PubMed ID: 9404448
[TBL] [Abstract][Full Text] [Related]
2. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.
Ahmad AM; Hopkins MT; Thomas J; Ibrahim H; Fraser WD; Vora JP
Clin Endocrinol (Oxf); 2001 Jun; 54(6):709-17. PubMed ID: 11422104
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
4. Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults.
Beshyah SA; Freemantle C; Shahi M; Anyaoku V; Merson S; Lynch S; Skinner E; Sharp P; Foale R; Johnston DG
Clin Endocrinol (Oxf); 1995 Jan; 42(1):73-84. PubMed ID: 7889635
[TBL] [Abstract][Full Text] [Related]
5. Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults.
Giavoli C; Cappiello V; Corbetta S; Ronchi CL; Morpurgo PS; Ferrante E; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2004 Jul; 61(1):81-7. PubMed ID: 15212648
[TBL] [Abstract][Full Text] [Related]
6. Effects of growth hormone replacement on physical performance and body composition in GH deficient adults.
Rodríguez-Arnao J; Jabbar A; Fulcher K; Besser GM; Ross RJ
Clin Endocrinol (Oxf); 1999 Jul; 51(1):53-60. PubMed ID: 10468965
[TBL] [Abstract][Full Text] [Related]
7. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.
Cuneo RC; Judd S; Wallace JD; Perry-Keene D; Burger H; Lim-Tio S; Strauss B; Stockigt J; Topliss D; Alford F; Hew L; Bode H; Conway A; Handelsman D; Dunn S; Boyages S; Cheung NW; Hurley D
J Clin Endocrinol Metab; 1998 Jan; 83(1):107-16. PubMed ID: 9435425
[TBL] [Abstract][Full Text] [Related]
8. The association between growth response to growth hormone and baseline body composition of children with growth hormone deficiency.
Esen I; Demirel F; Tepe D; Kara O; Koc N
Growth Horm IGF Res; 2013 Oct; 23(5):196-9. PubMed ID: 23890535
[TBL] [Abstract][Full Text] [Related]
9. The IGF-I response to very low rhGH doses is preserved in human ageing.
Arvat E; Ceda G; Ramunni J; Lanfranco F; Aimaretti G; Gianotti L; Broglio F; Ghigo E
Clin Endocrinol (Oxf); 1998 Dec; 49(6):757-63. PubMed ID: 10209563
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition.
Jørgensen JO; Vahl N; Hansen TB; Thuesen L; Hagen C; Christiansen JS
Clin Endocrinol (Oxf); 1996 Dec; 45(6):681-8. PubMed ID: 9039333
[TBL] [Abstract][Full Text] [Related]
11. Gender difference in the response of growth hormone (GH)-deficient adults to GH therapy.
Hayes FJ; Fiad TM; McKenna TJ
Metabolism; 1999 Mar; 48(3):308-13. PubMed ID: 10094105
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
[TBL] [Abstract][Full Text] [Related]
13. Long-term monitoring of insulin sensitivity in growth hormone-deficient adults on substitutive recombinant human growth hormone therapy.
Giavoli C; Porretti S; Ronchi CL; Cappiello V; Ferrante E; Orsi E; Arosio M; Beck-Peccoz P
Metabolism; 2004 Jun; 53(6):740-3. PubMed ID: 15164321
[TBL] [Abstract][Full Text] [Related]
14. Using dilution techniques and multifrequency bioelectrical impedance to assess both total body water and extracellular water at baseline and during recombinant human growth hormone (GH) treatment in GH-deficient adults.
Janssen YJ; Deurenberg P; Roelfsema F
J Clin Endocrinol Metab; 1997 Oct; 82(10):3349-55. PubMed ID: 9329367
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone therapy in GH-deficient adults: continuous vs alternate-days treatment.
Giavoli C; Cappiello V; Porretti S; Ronchi CL; Orsi E; Beck-Peccoz P; Arosio M
Horm Metab Res; 2003 Sep; 35(9):557-61. PubMed ID: 14517774
[TBL] [Abstract][Full Text] [Related]
16. Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years.
Wallymahmed ME; Foy P; Shaw D; Hutcheon R; Edwards RH; MacFarlane IA
Clin Endocrinol (Oxf); 1997 Oct; 47(4):439-46. PubMed ID: 9404442
[TBL] [Abstract][Full Text] [Related]
17. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of the peripheral sensitivity to growth hormone in adults with GH deficiency.
Aimaretti G; Fanciulli G; Bellone S; Maccario M; Arvat E; Delitala G; Camanni F; Ghigo E
Eur J Endocrinol; 2001 Sep; 145(3):267-72. PubMed ID: 11517006
[TBL] [Abstract][Full Text] [Related]
20. Effects of recombinant human growth hormone for 1 year on body composition and muscle strength in children on long-term steroid therapy: randomized controlled, delayed-start study.
Simon D; Alberti C; Alison M; Le Henaff L; Chevenne D; Boizeau P; Canal A; Ollivier G; Decostre V; Jacqz-Aigrain E; Carel JC; Czernichow P; Hogrel JY
J Clin Endocrinol Metab; 2013 Jul; 98(7):2746-54. PubMed ID: 23626006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
